Soligenix Competitors
| SNGX Stock | USD 0.38 0.02 5.00% |
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Soligenix competition on your existing holdings.
Soligenix |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Soligenix's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Soligenix Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Soligenix and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Soligenix and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Soligenix does not affect the price movement of the other competitor.
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Soligenix Stock performing well and Soligenix Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Soligenix's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ZURA | 4.59 | (0.14) | 0.00 | (0.09) | 0.00 | 13.07 | 42.14 | |||
| APGN | 3.15 | (0.39) | 0.00 | 1.20 | 0.00 | 6.52 | 19.80 | |||
| PHIO | 5.15 | 0.21 | 0.03 | 0.26 | 6.37 | 13.33 | 38.44 | |||
| EFTR | 6.86 | (1.44) | 0.00 | (0.19) | 0.00 | 11.60 | 98.22 | |||
| IMMX | 4.75 | (1.36) | 0.00 | (0.42) | 0.00 | 8.22 | 25.10 | |||
| ADXN | 5.58 | 1.67 | 0.29 | 1.35 | 4.59 | 20.92 | 37.95 | |||
| ACGN | 5.45 | (1.54) | 0.00 | 1.94 | 0.00 | 4.88 | 77.52 | |||
| ERYP | 4.72 | (0.10) | 0.00 | (0.52) | 0.00 | 12.68 | 46.27 | |||
| ATXI | 2.98 | (0.06) | (0.01) | 0.02 | 4.07 | 7.69 | 32.46 | |||
| PALI | 6.48 | 0.02 | 0.03 | 0.09 | 9.01 | 11.30 | 119.62 |
Cross Equities Net Income Analysis
Compare Soligenix and related stocks such as Zura Bio Limited, Apexigen, and Phio Pharmaceuticals Corp Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ZURA | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | 3.5 M | (60.4 M) | (57.3 M) |
| PHIO | (10.2 M) | (10.2 M) | (12.9 M) | (20.9 M) | (8.8 M) | (10.2 M) | (9 M) | (12.5 M) | (7.4 M) | (8.8 M) | (8.8 M) | (13.2 M) | (11.3 M) | (10.8 M) | (11.4 M) |
| EFTR | (29.7 M) | (29.7 M) | (29.7 M) | (29.7 M) | (29.7 M) | (29.7 M) | (29.7 M) | (29.7 M) | (29.7 M) | (29.7 M) | 14.2 M | 15.8 M | (12.9 M) | (35.8 M) | (34 M) |
| IMMX | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (972.8 K) | (1.1 M) | (24.4 M) | (8.2 M) | (15.4 M) | (16.2 M) |
| ADXN | (20.5 M) | (31.1 M) | (26.6 M) | (14.5 M) | (1.8 M) | (4.2 M) | (3.1 M) | (3.3 M) | (1.6 M) | (14.8 M) | (12.9 M) | (15.4 M) | (20.8 M) | (10.6 M) | (11.1 M) |
| ATXI | (5.2 M) | (5.2 M) | (5.2 M) | (5.2 M) | (5.2 M) | (5.2 M) | (3.2 M) | (12.3 M) | (21.3 M) | (25.6 M) | (5.1 M) | (3.7 M) | 2 M | (10.4 M) | (10.9 M) |
| PALI | (3.1 M) | (12.5 M) | (10.1 M) | (19.8 M) | (22.6 M) | (20.9 M) | (21.1 M) | (15.7 M) | (4.9 M) | (8.4 M) | (10.6 M) | (27.3 M) | (12.8 M) | (12.3 M) | (12.9 M) |
| ALLR | (14.4 M) | (14.4 M) | (14.4 M) | (14.4 M) | (14.4 M) | (14.4 M) | (14.4 M) | (14.4 M) | (14.4 M) | (14.4 M) | (5.1 M) | (26.6 M) | (16.1 M) | (11.9 M) | (12.5 M) |
| CNSP | (219.4 K) | (219.4 K) | (219.4 K) | (219.4 K) | (219.4 K) | (219.4 K) | (219.4 K) | (219.4 K) | (7.4 M) | (3.9 M) | (9.5 M) | (14 M) | (15.3 M) | (18.9 M) | (17.9 M) |
| WINT | (2.8 M) | (21 M) | (37.3 M) | (45.2 M) | (44.1 M) | (55.2 M) | (39.5 M) | (18.4 M) | (20.5 M) | (29.9 M) | (30.3 M) | (67.6 M) | (39.2 M) | (20.3 M) | (21.3 M) |
| DRMA | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (5 M) | (3.4 M) | (7.9 M) | (9.6 M) | (7.8 M) | (8.2 M) |
| ENSC | (31.2 K) | (31.2 K) | (31.2 K) | (31.2 K) | (31.2 K) | (31.2 K) | (31.2 K) | (31.2 K) | 2.1 M | 1.5 M | (938.7 K) | (29.1 M) | (25 M) | (10.6 M) | (11.2 M) |
| BXRX | (61.1 M) | (61.1 M) | (61.1 M) | (61.1 M) | (61.1 M) | (61.1 M) | (61.1 M) | (61.1 M) | (73.7 M) | (18 M) | (76.1 M) | (19.8 M) | (58.8 M) | (7.2 M) | (7.5 M) |
Soligenix and related stocks such as Zura Bio Limited, Apexigen, and Phio Pharmaceuticals Corp Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Soligenix financial statement analysis. It represents the amount of money remaining after all of Soligenix operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Soligenix Competitive Analysis
The better you understand Soligenix competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Soligenix's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Soligenix's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Soligenix Competition Performance Charts
Five steps to successful analysis of Soligenix Competition
Soligenix's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Soligenix in relation to its competition. Soligenix's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Soligenix in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Soligenix's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Soligenix, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Soligenix position
In addition to having Soligenix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sport Products Thematic Idea Now
Sport Products
Companies manufacturing sporting goods and accessories. The Sport Products theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sport Products Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Soligenix Correlation with its peers. For more information on how to buy Soligenix Stock please use our How to Invest in Soligenix guide.Note that the Soligenix information on this page should be used as a complementary analysis to other Soligenix's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Soligenix Stock analysis
When running Soligenix's price analysis, check to measure Soligenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Soligenix is operating at the current time. Most of Soligenix's value examination focuses on studying past and present price action to predict the probability of Soligenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Soligenix's price. Additionally, you may evaluate how the addition of Soligenix to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Soligenix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Soligenix. If investors know Soligenix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Soligenix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.79) | Revenue Per Share 0.108 | Quarterly Revenue Growth (0.33) | Return On Assets (0.40) | Return On Equity (237.84) |
The market value of Soligenix is measured differently than its book value, which is the value of Soligenix that is recorded on the company's balance sheet. Investors also form their own opinion of Soligenix's value that differs from its market value or its book value, called intrinsic value, which is Soligenix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Soligenix's market value can be influenced by many factors that don't directly affect Soligenix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Soligenix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Soligenix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Soligenix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.